Healthcare Industry News Weekly Wrap-Up: December 5, 2024
// Biotech and Pharma Therapeutics AstraZeneca’s Enhertu and Akeso’s bispecifics win national coverage in China as CAR-T therapies miss out again December 4, 2024 / China / Drug Costs / Drug Reimbursement / AstraZenecaAstraZeneca’s Enhertu, Akeso’s bispecific therapies, and others...
